Pharmaceutical Companies

(Reuters) - Teva Pharmaceutical Industries on Tuesday announced a $4.35 billion proposed nationwide settlement that could resolve thousands of lawsuits over the drugmaker's alleged role in the U.S. opioid epidemic.

CHARLESTON, W.Va. — A federal judge on Monday ruled in favor of three major U.S. drug distributors in a landmark lawsuit that accused them of causing a health crisis by distributing 81 million pills over eight years in one West Virginia county ravaged by opioid addiction.

Judge finds lawsuits allege deliberate, not accidental, conduct. McKesson says it has spent more than $270 million on opioid legal defense

Drugmaker Johnson & Johnson and three major distributors have finalized a nationwide settlement over their role in the opioid addiction crisis

6th Circuit cites risk of state, federal court friction. Ohio state courts are considering other opioid coverage disputes

Johnson & Johnson and its three largest drug distributors will pay a combined $26 billion to communities affected by the opioid crisis.

Over the next two weeks, some of the biggest U.S. corporations accused of "turbocharging" the opioid epidemic could finalize payouts to victims and governments worth roughly $32 billion.

Native American tribes have reached opioid settlements worth over a half-billion dollars with drugmaker Johnson & Johnson and three distributors